C Difficile - The Ultimate Challenge: Controlling the Spread
|
|
- Ariel Gregory
- 6 years ago
- Views:
Transcription
1 C Difficile - The Ultimate Challenge: Controlling the Spread Linda R. Greene, RN, MPS, CIC Manager of Infection Prevention Highland Hospital Rochester, NY University of Rochester Medical Center linda_greene@urmc.rochester.edu
2 The Big Picture C difficile lab ID reported through NHSN Proposed for Value Based Purchasing FY 2017
3 The Year 2009
4 A vital Energetic woman Friend, Mother and Grandmother
5
6
7
8 So what do we need to do? Engage Evaluate Educate Execute The Evidence based Model for Improvement
9 Strategies for Engagement Multidisciplinary Team Senior Leadership Putting names and faces to cases
10 Education
11 C difficile Now rivals MRSA as the most common organism found in hospitals Incidence outside the hospital may be more common than previously thought Associated with increased length of stay, morbidity and mortality
12 Impact of C. difficile infection (CDI) Hospital-acquired, hospital-onset: 165,000 cases, $1.3 billion in excess costs, and 9,000 deaths annually Hospital-acquired, post-discharge (up to 4 weeks): 50,000 cases, $0.3 billion in excess costs, and 3,000 deaths annually Nursing home-onset: 263,000 cases, $2.2 billion in excess costs, and 16,500 deaths annually Campbell et al. Infect Control Hosp Epidemiol. 2009:30: Dubberke et al. Emerg Infect Dis. 2008;14: Dubberke et al. Clin Infect Dis. 2008;46: Elixhauser et al. HCUP Statistical Brief #
13 Pathogenesis C. difficile is acquired by ingestion of spores from the hospital environment or hands of healthcare personnel Alteration of the intestinal flora by antibiotics leads to C. difficile proliferation in the colon Colonization Advanced age Multiple comorbidies No antibody to Toxin A/B Antibody to Toxin A/B C. difficile diarrhea No diarrhea
14 Ingested Normal flora interrupted Small Intestine Spores Germinate C Difficile toxins monocytes Pseudomembrane Toxin A attracts neutrophils and monocytes, and toxin B degrades the colonic epithelial cells, both leading to colitis, pseudomembrane formation, and watery diarrhea Neutrophils C difficile reproduces in the intestinal crypts, releasing toxins A and B, causing severe inflammation. Mucous and cellular debrisare expelled, leading to the formation of pseudomembranes
15 Pseudomembrenous Colitis Wolf P, Kasyan A N, Engl J - Med 2005;353:2491
16
17 I just touched the bed rail 100-1,000 bacteria transferred by: Pulling patients up in bed Taking a blood pressure or pulse Touching a patient s hand Rolling patients over
18 O² sat monitor Stethoscope
19 Keyboard & Mouse Med Keyboard
20 C Difficile in the enviornment C. difficile forms an endospore or a dormant state with increased resistance when conditions in the human or animal body or the environment become unfavorable for it to survive in its vegetative (actively growing) state. In the endospore stage, C. difficile spores will not be destroyed on environmental surfaces by disinfectants
21 Transmission- Fecal Oral Route o Mainly by direct contact with the hands of HCWs o Autoinoculation (oral ingestion) o Shed in feces o Indirect contact (inanimate objects such as commodes, etc) o Environmental contamination spores can survive for months in the environment
22 What s Wrong With This Picture
23 Another One
24 What are the symptoms of Cdiff? watery diarrhea fever loss of appetite nausea abdominal pain/tenderness (Be wary of lack of stools)
25 CDI Prevention Strategies: Core Contact Precautions for duration of diarrhea Hand hygiene in compliance with CDC/WHO Cleaning and disinfection of equipment and environment Laboratory-based alert system for immediate notification of positive test results Educate about CDI: HCP, housekeeping, administration, patients, families Dubberke et al. Infect Control Hosp Epidemiol 2008;29:S SEE ALSO: Cohen SP, et al. SHEA/IDSA Clinical Practice Guideline, ICHE May 2010
26 Bundle Monitoring Tool
27 The Compendium
28 Outbreak or Hyper-endemic Setting only
29
30 Hyper-endemic levels
31
32
33
34 Other Issues Lab ID is a marker. May also pick up colonization What are your criteria for sending a specimen Any Inappropriate testing? Testing methods PCR 2 STEP Toxin- A and B antigen
35 Renewed Respect for Role of the Environment: Who s Been in the Room Before or With You? Huang SS (2006); Drees M (2008); Zhou Q (2008); Moore C (2008);Hamel M (2010) All documented increased risk of acquisition of VRE, MRSA, &/or CDI when admitted to room where prior occupant had one of these or if in multi-occupancy room So what s the answer?
36 What s The Answer? They need to get a life Keep Going No Doesn t Look clean yet
37 Sharing Best Practices NYC- Dr. Brian Koll Administrative Clinical Physician and Nursing Champions
38 Teach Teamwork Infection Prevention Coach Training Program Monitor and enforce practices Problem-solve Share and spread best practices Participation in hospital forums Environment of Care
39 Measuring and assessing effectiveness Reducing CDI Feedback Sustainability Dissemination and Spread Web based and electronic communication
40 Infection Prevention Bundles
41 C. difficile Infection Prevention Bundle Hand hygiene (washing with soap and water for C. difficile) Contact precautions Sign placement PPE readily available / used Dedicated rectal thermometers Patient placement private room vs. cohorting vs. shared Bathrooms dedicated vs. shared vs. commode Transport precautions Environmental cleaning hypochlorite-based disinfectant daily and terminal cleaning procedures
42 Environmental Checklist
43 New Technologies
44 Other Measures Prevent other Infections UTI S use of florquinoles highly associated with C Difficile
45 The Bottom Line It s like eating an elephant 1 bite at a time
6/14/2012. Welcome! PRESENTATION OUTLINE CLOSTRIDIUM DIFFICILE PREVENTION. Teaming Up to Prevent Infections! 1) Impact. 2) Testing Recommendations
CLOSTRIDIUM DIFFICILE PREVENTION Beth Goodall, RN, BSN Board Certified in Infection Prevention and Control DCH Health System Epidemiology Director Welcome! Teaming Up to Prevent Infections! CLOSTRIDIUM
More informationClostridium difficile Essential information
Clostridium difficile Essential information Clostridium difficile Origins Clostridium difficile (C. diff) is a Gram positive, spore forming, anaerobic bacterium with a rod structure. It was first identified
More informationMarch 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments
March 3, 2010 To: Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Bureau of Healthcare Associated Infections HEALTH ADVISORY: GUIDANCE FOR PREVENTION AND CONTROL OF HEALTHCARE
More informationThe incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment.
C. DIFFICILE Case definition CONFIRMED CASE A patient is defined as a case if they are one year of age or older AND have one of the following requirements: A laboratory confirmation of a positive toxin
More informationClostridium difficile Infection: Diagnosis and Management
Clostridium difficile Infection: Diagnosis and Management Brian Viviano D.O. Case study 42 year old female with history of essential hypertension and COPD presents to ED complaining of 24 hours of intractable,
More informationClostridium difficile
Clostridium difficile Care Homes IPC Study Day Sue Barber Infection Prevention & Control Lead AV & Chiltern CCG s Clostridium difficile A spore forming Bacterium. Difficult to grow in the laboratory hence
More informationActivity C: ELC Prevention Collaboratives
Clostridium difficile il (CDI) Infections Toolkit Activity C: ELC Prevention Collaboratives Carolyn Gould, MD MSCR Cliff McDonald, MD, FACP Division of Healthcare Quality Promotion Centers for Disease
More informationDiagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review
Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review October 18, 2010 James Kahn and Carolyn Kenney, MSIV Overview Burden of disease associated
More informationC. difficile: The Changing Epidemiology Evaluations Clostridium difficile Thank You to our Sponsors
C. difficile: The Changing Epidemiology Ghinwa Dumyati, MD University of Rochester Monroe County Department of Public Health Thank You to our Sponsors Evaluations School of Public Health, University at
More informationObjectives Clostridium difficile Infections, So Many Tests, Which One to Choose?
Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? March 9, 0 http://www.slh.wisc.edu/outreach-data/event-detail.php?id=03 Raymond P. Podzorski, Ph.D., D(ABMM) Clinical Microbiologist
More informationThe Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH
The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH Some history first Clostridium difficile, a spore-forming gram-positive (i.e., thick
More informationENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE
ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE The diagnosis of CDI should be based on a combination of clinical and laboratory findings. A case definition for the usual
More informationClostridium difficile: An Overview
Clostridium difficile: An Overview CDI Webinar July 11, 2017 PUBLIC HEALTH DIVISION Acute and Communicable Disease Prevention Section Outline Background Microbiology Burden Pathogenesis Diagnostic testing
More informationCONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES
CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES California Department of Health Services Division of Communicable Disease Control In Conjunction with Licensing and Certification
More informationWhat s the diff with C. diff.? Accelerating Prevention Using a Bundle Approach
What s the diff with C. diff.? Accelerating Prevention Using a Bundle Approach GHA Learning & Action Network - 01/13/16 Russ Olmsted Dir., Infection Prevention & Control (IPC) System Office, Livonia olmstedr@trinity-health.org
More informationPreventing & Controlling the Spread of Infection
Preventing & Controlling the Spread of Infection Contributors: Alice Pong M.D., Hospital Epidemiologist Chris Abe, R.N., Senior Director Ancillary and Support Services Objectives Review the magnitude of
More informationPrevention and Control of Healthcare-Associated Norovirus
Purpose: Audience: Policy: To prevent healthcare-associated norovirus infections in patients, employees, contract workers, volunteers, visitors and students and to control and eradicate norovirus infections
More informationInfection control in Aged Residential Care Facilities. Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB
Infection control in Aged Residential Care Facilities Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB Background Endemic infections Epidemic infections Managing outbreaks Administrative measures
More informationCURRENT INFECTIOUS DISEASE ISSUES. 11/2/15 Regina Won, MD
CURRENT INFECTIOUS DISEASE ISSUES 11/2/15 Regina Won, MD Disclosures None Objectives Discuss common organisms seen on the wards Discuss infection control issues associated with these common organisms Discuss
More informationCase 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?
Case 1 21 yr old HIV +ve, Cd4-100 HAART naïve Profuse diarrhoea for 3/52. Stool MC&S ve Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Repeat stool MC&S Stool
More informationClostridium difficile
Clostridium difficile Infection Control Team Patient Information Leaflet What is Clostridium difficile? Clostridium difficile (sometimes called C. diff) is a type of bacteria. They live in the intestine
More informationGetting to Know You. Tackling Clostridium difficile in Nursing Homes. Outline. C. difficile Epidemiology 11/18/2013
Tackling Clostridium difficile in Nursing Homes Getting to Know You Emily Lutterloh, MD, MPH Director, Bureau of Healthcare Associated Infections New York State Department of Health Outline Getting to
More informationNorovirus Outbreak in a Children s Hospital. Jennifer Adams, MT, MPH, CIC April 23, 2015
Norovirus Outbreak in a Children s Hospital Jennifer Adams, MT, MPH, CIC April 23, 2015 Objectives Discuss the epidemiology, symptoms, and transmission of norovirus. Identify key infection control activities
More informationFIGHT INFECTIOUS BACTERIA AND VIRUSES MAKE HANDWASHING CONTAGIOUS!!!!!!!!!!!!!!!!!!!!!!!!!!!
FIGHT INFECTIOUS BACTERIA AND VIRUSES MAKE HANDWASHING CONTAGIOUS!!!!!!!!!!!!!!!!!!!!!!!!!!! It s contagious!! HANDWASHING TO ATTACK NOROVIRUS!! HELP FIGHT INFECTIOUS BACTERIA AND VIRUSES MAKE HANDWASHING
More informationClostridioides difficile Infection: What s the BIG Stink?
Clostridioides difficile Infection: What s the BIG Stink? GLORIA MATHIS, RN, BSN, CIC 29 TH ANNUAL MEDICAL SURGICAL CONFERENCE APRIL 4, 2019 SAN FRANCISCO, CA I am sre my patient has C. diff. I cold smell
More informationJourney to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer
Journey to Decreasing Clostridium Difficile and the Unexpected Twist Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer 4/13/2018 Objectives Discuss the organism and clinical
More informationStony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics
Stony Brook Adult Clostridium difficile Management Guidelines Summary: Use of the C Diff Infection (CDI) PowerPlan (Adult) Required Patient with clinical findings suggestive of Clostridium difficile infection
More informationBacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 48 Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others Authors Olivier Vandenberg, MD, PhD Michèle
More informationClostridium difficile infection surveillance: Applying the case definition
Clostridium difficile infection surveillance: Applying the case definition PICNet Conference March 3 rd 2016 Presented by: Tara Leigh Donovan, MSc Managing Consultant (Former Epidemiologist) 1 Disclaimer
More informationPrevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela
Chapter 19 Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela Key Points Noroviruses are the commonest cause of healthcare-associated gastroenteritis. Isolation
More informationInfection Control Road Show 2011 Outbreak Management
Infection Control Road Show 2011 Outbreak Management Today s Agenda LTCH Road Show Road Map for the day How can you, the management team, support infection prevention and control and promote infection
More informationmore intense treatments are needed to get rid of the infection.
What Is Clostridium Difficile (C. Diff)? Clostridium difficile, or C. diff for short, is an infection from a bacterium that can grow in your intestines and cause bad GI symptoms. The main risk of getting
More informationCDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers
Disclosures No conflict of interest to declare Acknowledgments Objectives and Agenda Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Guidelines
More informationSurviving Norovirus. Not Just a Cruise Ship Issue. Maria Wellisch, RN, LFNA Vice President of Corporate Education Morningside Ministries
Surviving Norovirus Not Just a Cruise Ship Issue Maria Wellisch, RN, LFNA Vice President of Corporate Education Morningside Ministries How Prevalent is Norovirus 21 million cases 71,000 individuals hospitalized
More informationHealthStream Regulatory Script
HealthStream Regulatory Script [Transmission-Based Precautions: Contact and Droplet] Version: [April 2005] Lesson 1: Introduction Lesson 2: Contact Precautions Lesson 3: Droplet Precautions Lesson 1: Introduction
More informationInfection Prevention & Control Core Skills Level 2
Infection Prevention & Control Core Skills Level 2 Learning outcomes Risk assessment of patients Critical examination of the situation MRSA, CDT & CPE Ongoing challenges future-proofing infection control
More informationUnderstanding C. diff. atomalliance.org/cdifftraining
Understanding C. diff atomalliance.org/cdifftraining This booklet is a printed guide of the online educational resource atomalliance.org/cdifftraining Target Audience Understanding C. diff This educational
More informationChapter 12 Preventing Infection
Chapter 12 Preventing Infection Infection is a major safety and health hazard. Minor infections cause acute illnesses and some infections are serious and can cause death. Microbe/microorganism is a small
More informationEpidemiology and Risk of Infection in outpatient Settings
Module C Epidemiology and Risk of Infection in outpatient Settings Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine Objectives Discuss the infectious process through
More informationEpidemiology and Risk of Infection in outpatient Settings
Module C Epidemiology and Risk of Infection in outpatient Settings Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine Objectives Discuss the infectious process through
More informationCohorting in Acute Care Impact on LTC Resident Repatriation During an Outbreak
Cohorting in Acute Care Impact on LTC Resident Repatriation During an Outbreak Gary E Garber MD FRCPC FACP Medical Director- IPAC Public health Ontario Objectives Why talk about cohorting? Cohorting when
More informationLos Angeles County Department of Public Health: Your Partner in CDI Prevention
Los Angeles County Department of Public Health: Your Partner in CDI Prevention Dawn Terashita, MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public Health dterashita@ph.lacounty.gov
More informationDoc: 1.9. Course: Patient Safety Solutions. Topic: Infection prevention and control. Summary
Course: Patient Safety Solutions Topic: Infection prevention and control Summary Health care-associated Infection (HCAI) is defined as an infection acquired in a hospital by a patient who was admitted
More informationA Pharmacist Perspective
Leveraging Technology to Reduce CDI A Pharmacist Perspective Ed Eiland, Pharm.D., MBA, BCPS (AQ-ID) Clinical Practice and Business Supervisor Huntsville Hospital System Huntsville Hospital 881 licensed
More informationEPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI)
EPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics & Epidemiology Associate Chief Medical Offer, UNC Health Care Medical
More informationHEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile
OBJECTIVES HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile Identify and describe the pathophysiology of C. diff. Identify and describe current therapies in treatment of C. diff Identify
More informationClostridium difficile Infection (CDI) What is it? Modes of transmission? Environmental Sources? Control Measures?
Clostridium difficile Infection (CDI) What is it? Modes of transmission? Environmental Sources? Control Measures? Clostridium difficile Clostridium difficile - first described in 1935 when it was isolated
More informationC. Difficile Testing Protocol
C. Difficile Testing Protocol Caroline Donovan, RN, BSN, ONC- Infection Control Practitioner Abegail Pangan, RN, MSN, CIC- Infection Control Practitioner U.S. NEWS & WORLD REPORT 2017 2018 RANKINGS Acute
More informationISOLATION PRECAUTIONS. Karen Hoffmann RN, MS, CIC, FSHEA, FAPIC
ISOLATION PRECAUTIONS Karen Hoffmann RN, MS, CIC, FSHEA, FAPIC 2006 Management Of Resistant O In Healthcare Settings 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents
More informationAn APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings
An APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings About APIC APIC s mission is to improve health and patient safety by reducing risks of infection and other adverse
More informationInfection Control Standard Precautions and Isolation
Infection Control Standard Precautions and Isolation Michael Bell, M.D. Division of Healthcare Quality Promotion Centers for Disease Control and Prevention History of Infection Control Precautions in the
More informationABSTRACT PURPOSE METHODS
ABSTRACT PURPOSE The purpose of this study was to characterize the CDI population at this institution according to known risk factors and to examine the effect of appropriate evidence-based treatment selection
More informationSafe Patient Care Keeping our Residents Safe
Safe Patient Care Keeping our Residents Safe 2016 Diarrhoea & Vomiting Infection Prevention & Control in Residential Care Setting Patricia Coughlan, Infection Prevention Control Nurse, HSE Disability Services
More informationPrinciples and Practices of Asepsis
Module E Objectives Principles and Practices of Asepsis Role of hands and the environment in disease transmission Describe the principles and practice of asepsis Understand hand hygiene Understand the
More information2018 UPDATE. INFECTION PREVENTION and CONTROL ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS
2018 UPDATE INFECTION PREVENTION and CONTROL ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS Catherine D. Bacheller, M.D. Medical Director, KMC & GVMC Infection Prevention and Control Assistant Professor
More informationManagement of Gastroenteritis Outbreaks. Approval Signature: Date of Approval: March 4, 2010 Review Date: March 2013
Personal Care Home/Long Term Care Facility Infection Prevention and Control Program Operational Directive Management of Gastroenteritis Outbreaks Approval Signature: Date of Approval: March 4, 2010 Review
More informationRole of Environmental Cleaning in Infection Prevention and Control
Role of Environmental Cleaning in Infection Prevention and Control September 28, 2012 Marilyn Weinmaster RN BScN, CIC Regina Qu Appelle Health Region mweinmaster@rqhealth.ca Health Care Setting Any location
More informationVIII Congresso Nazionale Maggio 2018
VIII Congresso Nazionale Attualità e prospettive nella prevenzione e controllo delle infezioni nelle organizzazioni sanitarie 21-23 Maggio 2018 Bergamo, Ospedale Papa Giovanni XXIII Clostridium difficile
More informationConfronting Ebola. Keeping NY patients and healthcare workers safe and healthy
Confronting Ebola Keeping NY patients and healthcare workers safe and healthy All materials provided by Centers for Disease Control and Prevention. October 16, 2014 What You Need to Know about Ebola The
More informationWELCOME TO Scott &White Infection Prevention
WELCOME TO Scott &White Infection Prevention Scott and White Needs YOU To prevent infections to patients Hand washing is the single best way to keep from spreading infections or germs to others! Preventable
More informationFecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection
Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection Issue Date: June 2013 Vol. 8 No. 6 Author: Amy Marinski, MSN, RN, CCRN, CNL More than 3 million new cases of Clostridium
More informationSelf-Instructional Packet (SIP)
Self-Instructional Packet (SIP) Advanced Infection Prevention and Control Training Module 1 Intro to Infection Prevention Control February 11, 2013 Page 1 Learning Objectives Module One Introduction to
More informationOBJECTIVES PEOPLE AS RESERVOIRS. Reservoir
Module C EPIDEMIOLOGY AND RISK OF INFECTION IN OUTPATIENT SETTINGS Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine OBJECTIVES Discuss the infectious process Review
More informationHealthcare-associated infections surveillance report
Healthcare-associated infections surveillance report Clostridium difficile Infections (CDI) Update, Q1 of 2017/18 Summary Table Q1 2017/18 Previous quarter (Q4 2016/17)* Same quarter of previous year (Q1
More informationDISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit
GASTROENTERITIS DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest within this presentation fidaxomicin (which
More informationBLOODBORNEPATHOGENS. CAP Safety Meetings. Revision: CAP Safety Meetings [Bloodborne Pathogens]
BLOODBORNEPATHOGENS CAP Safety Meetings Revision: 10-2011 2011 Copyright - PEC/Premier Safety Management, Inc. All Rights Reserved Revision: [10-2011] 1 THEBLOODBORNEPATHOGENSSTANDARD The Bloodborne Pathogens
More informationLourdes Hospital Infection Prevention and Control
Lourdes Hospital Infection Prevention and Control Lourdes Infection Prevention Program Ultimate goal: To protect the patient To protect the healthcare workers, visitors and others in the environment To
More informationAnnex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening
Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening There s an updated Annex C Annex C is an extension to the PIDAC Infection Prevention
More informationHand Hygiene for Clinical Staff
Hand Hygiene for Clinical Staff Volunteer Annual Review 2017 Why All the Fuss About Hand Hygiene? Most common mode of transmission of pathogens is via hands! What is Hand Hygiene? Hand Hygiene means cleaning
More information2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key
Name: School: Instructor: Date: 2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key For questions about this test, contact Infection Prevention and Control at 678-312-3308. 1. When do you
More informationAlberta Health and Wellness Public Health Notifiable Disease Management Guidelines August 2011
August 2011 Campylobacteriosis Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) August 2011 August 2011 October 2005 Case
More informationKatie Obergfell BSN, RN CIC Karen Brody BSN, RN
Katie Obergfell BSN, RN CIC Karen Brody BSN, RN Purpose of Infection Prevention Chain of Infection Standard Precautions Multi-Drug Resistant Organisms Isolation Procedures Blood borne Pathogens TB Employee
More informationECHO-Antibiotic Stewardship Program
ECHO-Antibiotic Stewardship Program More Interesting Recent Literature Updates April 20, 2017 Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Antibiotic
More informationThe term Routine Practices is used to describe practices that were previously known as Universal Precautions.
Health & Safety Manual Health Promotion & Wellness ROUTINE PRACTICES PROCEDURES INTRODUCTION The term Routine Practices is used to describe practices that were previously known as Universal Precautions.
More informationHealthcare-associated infections surveillance report
Healthcare-associated infections surveillance report Clostridium difficile Infections (CDI) Update, Q2 of 2018/19 Summary Table Q2 2018/19 Previous quarter (Q1 2018/19) Same quarter of previous year (Q2
More informationWhat is C difficile? (Clostridium difficile) Patient information leaflet
What is C difficile? (Clostridium difficile) Patient information leaflet What is C difficile? C difficile is short for Clostridium difficile, a rod-shaped bug that lives in the bowel of less than 5% of
More informationClostridium difficile Infection (CDI) Management Guideline
Clostridium difficile Infection (CDI) Management Guideline Do not test all patients with loose or watery stools for CDI o CDI is responsible for
More informationL. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015
Controversies and Current Issues in Diagnosis, Surveillance, and Treatment of Clostridium difficile infeciton L. Clifford McDonald, MD Senior Advisor for Science and Integrity September 16, 2015 Division
More information2019 UPDATE 1/9/ ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS. Healthcare-Associated Infections (HAIs) INFECTION PREVENTION and CONTROL
DC* DC* 219 UPDATE INFECTION PREVENTION and CONTROL Healthcare-Associated Infections (HAIs) ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS Catherine D. Bacheller, M.D. Medical Director, KMC & GVMC Infection
More informationImpact of hospital infections on our
Impact of hospital infections on our ageing population Professor Peter Lambert School of Life and Health Sciences P. A. Lambert Slides are for personal use only. They are NOT for reproduction or publication
More informationThe epidemiology of Clostridium difficile infection (CDI) in hospitals, longterm care and the community. J Scott Weese DVM DVSc DipACVIM
The epidemiology of Clostridium difficile infection (CDI) in hospitals, longterm care and the community J Scott Weese DVM DVSc DipACVIM C. difficile Gram positive anaerobic sporeforming bacterium first
More informationGiardiasis Surveillance Protocol
Provider Responsibilities 1. Report all cases to your local health department by completing the provider section of the WVEDSS form within the timeframe indicated: Sporadic case of - should be reported
More informationNorovirus in Long Term Care Facilities Outbreak Checklist
Norovirus in Long Term Care Facilities Outbreak Checklist Norovirus Description The typical symptoms are nausea, vomiting, fever, abdominal cramps, and watery non-bloody diarrhea. The usual incubation
More informationGastroenteritis Outbreaks Including Norovirus. Module 7
Gastroenteritis Outbreaks Including Norovirus Module 7 Learner Outcomes By the end of this module you will be able to: Outline the case definition for a gastroenteritis outbreak. Explain the difference
More informationEDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE
EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click
More informationTITLE OF PRESENTATION
TITLE OF PRESENTATION Can C. Subtitle difficile of Infection Presentation Rates Be Used to Judge Prevention Success for Hospitals? David P. Calfee, MD, MS Associate Professor of Medicine and Public Health
More informationEmergency Preparedness: Pandemics and Bioterrorism. Amber Wood, RN, BSN, CPN Infection Preventionist
Emergency Preparedness: Pandemics and Bioterrorism Amber Wood, RN, BSN, CPN Infection Preventionist November 11, 2011 Objectives What is your role/perspective? 33% 33% 33% 1. Clinical 2. Non-Clinical 3.
More information8. Infection Prevention And Control
PATIENT SAFETY 436 TEAM 8. Infection Prevention And Control Objectives: List The Modes Of Infection Transmission In Health-care Settings Explain Main Causes And Types Of Health Care-associated Infection
More informationHand Hygiene: Preventing avoidable harm in our care
Hand Hygiene: Preventing avoidable harm in our care Hand Hygiene Training Presentation for Healthcare Workers in Community and Primary Care National HSE HCAI AMR Clinical Programme 2017 What we will cover
More informationInfection Control Sec. 1, Unit 5 Part 1
Infection Control Sec. 1, Unit 5 Part 1 Introduction Infections are a significant cause of illness, disease and death for residents that reside in certain living situations including nursing facilities.
More informationMDROs and other exciting things What You Need to Know in Long-Term Care
MDROs and other exciting things What You Need to Know in Long-Term Care 1 April 12, 2018 Toni Foos, RN, BSN, CIC Infection Prevention Manager Colorado Hospital Association Today s Call is Provided by Telligen
More informationInfection Control for Anesthesia Personnel
Infection Control for Anesthesia Personnel 2017 A leading cause of death and increased morbidity for hospitalized ptns Hospitals, nursing homes, long-term care facilities, home care settings Higher rate
More informationInfection Prevention Special Needs Shelters. Jacqueline Whitaker RN MS LHRM CPHQ CIC FAPIC
Infection Prevention Special Needs Shelters Jacqueline Whitaker RN MS LHRM CPHQ CIC FAPIC Infection Prevention: Objectives and Your Role Know the client population and its impact on the special needs shelter
More informationCONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08
CONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08 The growth of infections caused by Clostridium difficile (C.diff) is a highly alarming trend in hospitals today. In 1993
More informationCLOSTRIDIUM DIFFICILE
Other useful information sources NHS Choices: www.nhs.uk NHS 111 (for urgent medical help that is not a 999 emergency) Public Health England: www.phe.gov.uk National Patient Safety Agency - www.npsa.nhs.uk/cleanyourhands
More informationPatient Safety Summit 2014
Patient Safety Summit 2014 The War on C Diff Mark Mellow, MD + C Diff The Organism Gram + bacillus Anaerobic Spore forming Intestinal flora (up to 35% hospitalized patients, 3% of healthy adults) Leading
More informationInfection Control Handout
Modes of Transmission Contact Routes Direct Contact Transmission Indirect Contact Transmission Droplet Transmission Indirect contact contamination Clothes Soiled bed linen Personal care products Personal
More informationEnteric Illness. Shigellosis
Section 3 Page 1 of 7 Notification Timeline: From Lab/Practitioner to Public Health: Immediately. From Public Health to Saskatchewan Health: Within 72 hours. Public Health Follow-up Timeline: Initiate
More information9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)
Clostridium Difficile: Updates on Diagnosis and Treatment Elizabeth Hudson, DO, MPH 9/25/18 Antibiotic-associated diarrhea and colitis were well established soon after widespread use of antibiotics In
More informationNew Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility
New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility Gerald A. Capraro, Ph.D., D(ABMM) Director, Clinical Microbiology Carolinas Pathology Group Atrium
More information